Breaking News Instant updates and real-time market news.

INVA

Innoviva

$15.90

(0.00%)

09:32
04/19/18
04/19
09:32
04/19/18
09:32

Innoviva initiated with a Buy at Berenberg

Berenberg analyst Patrick Trucchio initiated Innoviva with a Buy and $22 price target.

INVA Innoviva
$15.90

(0.00%)

05/01/17
COWN
05/01/17
NO CHANGE
Target $16
COWN
Outperform
Innoviva weakness a buying opportunity, says Cowen
Cowen analyst Tyler Van Buren said the recent earnings miss at Innoviva was largely non-fundamental and impacted by pressures that he expects will reverse in Q2. He said prescriptions look great and he views the weakness in Innoviva shares as a buying opportunity. Van Buren reiterated his Outperform rating and $16 price target on Innoviva shares.
11/20/17
DBAB
11/20/17
INITIATION
Target $13
DBAB
Hold
Innoviva initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Esther Rajavelu started Innoviva (INVA) with a Hold rating and $13 price target. The analyst is concerned about revenue concentration and sees no near-term growth opportunities outside of the GlaxoSmithKline (GSK) partnership.
11/20/17
11/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Innoviva (INVA) initiated with a Hold at Deutsche Bank. 2. National Vision (EYE) was initiated with an Overweight at Morgan Stanley, an Outperform at Wells Fargo, a Buy at Jefferies and Citi, as well as a Neutral at Goldman Sachs, UBS, and BofA/Merrill. 3. Ablynx (ABLX) was initiated with an Overweight at JPMorgan, an Outperform at Baird, and a Buy at Ladenburg. 4. Blue Apron (APRN) initiated with a Sector Weight at KeyBanc. 5. BP Midstream (BPMP) was initiated with an Overweight at JPMorgan, a Buy at UBS and Citi, an Equal Weight at Morgan Stanley and Barclays, as well as a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/18/17
MSCO
12/18/17
NO CHANGE
MSCO
Morgan Stanley sees opportunities in biotech amid 'limited' investor conviction
With clinical catalysts in large-cap Biotechnology limited to only five key Phase III readouts - three of which are from Alexion (ALXN) - investors are describing their 2018 picks in the space as the "least worst" of the group, according to Morgan Stanley analyst Matthew Harrison. However, he believes this lack of conviction creates real opportunity for outsized moves in 2018, with Amgen (AMGN) identified by Harrison as the biggest potential beneficiary of M&A given "its likely newfound access" to about $39B in offshore cash. Other biotech names the analyst highlights on the up side include Biogen (BIIB), BioMarin (BMRN), Biohaven (BHVN) and Sarepta (SRPT). Meanwhile, Harrison highlights his concerns about potential downside for BioVerativ (BIVV) and Innoviva (INVA), on both of which he keeps Underweight ratings.

TODAY'S FREE FLY STORIES

BBY

Best Buy

$77.70

0.67 (0.87%)

, SEAS

SeaWorld

$31.20

0.02 (0.06%)

07:30
09/19/18
09/19
07:30
09/19/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

BBY

Best Buy

$77.70

0.67 (0.87%)

SEAS

SeaWorld

$31.20

0.02 (0.06%)

BGS

B&G Foods

$30.30

-1.25 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 06

    Nov

QCOM

Qualcomm

$74.73

1.48 (2.02%)

07:30
09/19/18
09/19
07:30
09/19/18
07:30
Recommendations
Qualcomm analyst commentary  »

Qualcomm price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:30
09/19/18
09/19
07:30
09/19/18
07:30
General news
Treasury Market Outlook: yields cheapened overnight »

Treasury Market Outlook:…

JMP

JMP Group

$5.31

0.015 (0.28%)

07:29
09/19/18
09/19
07:29
09/19/18
07:29
Conference/Events
JMP Group management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

EGN

Energen

$79.34

1.2 (1.54%)

07:29
09/19/18
09/19
07:29
09/19/18
07:29
Downgrade
Energen rating change  »

Energen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$241.58

-14.22 (-5.56%)

07:27
09/19/18
09/19
07:27
09/19/18
07:27
Conference/Events
FedEx management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 03

    Oct

  • 04

    Oct

SBRA

Sabra Health Care

$23.32

-0.04 (-0.17%)

07:26
09/19/18
09/19
07:26
09/19/18
07:26
Initiation
Sabra Health Care initiated  »

Sabra Health Care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IOTS

Adesto Technologies

$6.05

-0.05 (-0.82%)

07:26
09/19/18
09/19
07:26
09/19/18
07:26
Recommendations
Adesto Technologies analyst commentary  »

Adesto Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 09

    Oct

NBIX

Neurocrine

$120.32

3.03 (2.58%)

07:25
09/19/18
09/19
07:25
09/19/18
07:25
Recommendations
Neurocrine analyst commentary  »

Cantor more confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:25
09/19/18
09/19
07:25
09/19/18
07:25
General news
FX Update: The dollar traded mostly softer »

FX Update: The dollar…

PGR

Progressive

$69.68

1.15 (1.68%)

07:24
09/19/18
09/19
07:24
09/19/18
07:24
Recommendations
Progressive analyst commentary  »

Progressive price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIR

Select Income REIT

$20.53

-1.18 (-5.44%)

, GOV

Government Properties

$11.82

-0.885 (-6.97%)

07:23
09/19/18
09/19
07:23
09/19/18
07:23
Upgrade
Select Income REIT, Government Properties, Industrial Logistics Property Trust rating change  »

Morgan Stanley upgrades…

SIR

Select Income REIT

$20.53

-1.18 (-5.44%)

GOV

Government Properties

$11.82

-0.885 (-6.97%)

ILPT

Industrial Logistics Property Trust

$20.95

-0.82 (-3.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$732.74

-14.79 (-1.98%)

07:21
09/19/18
09/19
07:21
09/19/18
07:21
Recommendations
AutoZone analyst commentary  »

AutoZone's weaker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

ATHN

Athenahealth

$135.25

-8.005 (-5.59%)

07:19
09/19/18
09/19
07:19
09/19/18
07:19
Recommendations
Athenahealth analyst commentary  »

Athenahealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETFC

E-Trade

, SCHW

Charles Schwab

$50.63

0.31 (0.62%)

07:19
09/19/18
09/19
07:19
09/19/18
07:19
Upgrade
E-Trade, Charles Schwab, TD Ameritrade rating change  »

Jefferies upgrades…

ETFC

E-Trade

SCHW

Charles Schwab

$50.63

0.31 (0.62%)

AMTD

TD Ameritrade

$55.42

0.24 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

AOS

A.O. Smith

$59.31

-0.12 (-0.20%)

07:18
09/19/18
09/19
07:18
09/19/18
07:18
Recommendations
A.O. Smith analyst commentary  »

A.O. Smith site tour…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$30.22

-0.05 (-0.17%)

, C

Citi

$71.38

0.49 (0.69%)

07:16
09/19/18
09/19
07:16
09/19/18
07:16
Recommendations
Bank of America, Citi, CIT Group, Goldman Sachs analyst commentary  »

U.S. banks 'in very…

BAC

Bank of America

$30.22

-0.05 (-0.17%)

C

Citi

$71.38

0.49 (0.69%)

CIT

CIT Group

$52.89

-0.35 (-0.66%)

GS

Goldman Sachs

$228.95

1.19 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 23

    Sep

  • 25

    Sep

  • 25

    Sep

  • 27

    Sep

  • 21

    Oct

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 12

    Oct

07:15
09/19/18
09/19
07:15
09/19/18
07:15
General news
Oil Action: Front-month WTI crude prices are near net unchanged »

Oil Action: Front-month…

VLKAY

Volkswagen

$0.00

(0.00%)

, F

Ford

$9.58

0.025 (0.26%)

07:13
09/19/18
09/19
07:13
09/19/18
07:13
Hot Stocks
EU passenger car registrations up 10.5% in July, up 31.2% in August »

In July, demand for new…

VLKAY

Volkswagen

$0.00

(0.00%)

F

Ford

$9.58

0.025 (0.26%)

TM

Toyota

$125.06

2.6 (2.12%)

NSANY

Nissan

$0.00

(0.00%)

HMC

Honda

$29.69

0.725 (2.50%)

GM

General Motors

$35.11

0.09 (0.26%)

FCAU

Fiat Chrysler

$17.62

0.17 (0.97%)

DDAIF

Daimler AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

, VKTX

Viking Therapeutics

$19.47

9.07 (87.21%)

07:13
09/19/18
09/19
07:13
09/19/18
07:13
Recommendations
Ligand, Viking Therapeutics analyst commentary  »

Ligand price target…

LGND

Ligand

VKTX

Viking Therapeutics

$19.47

9.07 (87.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 01

    Oct

  • 06

    Nov

ATVI

Activision Blizzard

$79.64

0.76 (0.96%)

, EA

Electronic Arts

$112.66

-0.03 (-0.03%)

07:12
09/19/18
09/19
07:12
09/19/18
07:12
Recommendations
Activision Blizzard, Electronic Arts, Take-Two, Ubisoft, Zynga analyst commentary  »

KeyBanc says buy shares…

ATVI

Activision Blizzard

$79.64

0.76 (0.96%)

EA

Electronic Arts

$112.66

-0.03 (-0.03%)

TTWO

Take-Two

$132.69

1.19 (0.90%)

UBSFY

Ubisoft

$0.00

(0.00%)

ZNGA

Zynga

$4.03

0.08 (2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 30

    Oct

BYSI

BeyondSpring

$25.55

-0.45 (-1.73%)

07:11
09/19/18
09/19
07:11
09/19/18
07:11
Hot Stocks
BeyondSpring granted new patent for Plinabulin by USPTO »

BeyondSpring announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPEY

Galp Energia

$0.00

(0.00%)

07:09
09/19/18
09/19
07:09
09/19/18
07:09
Downgrade
Galp Energia rating change  »

Galp Energia downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSDT

Helius Medical

$9.63

-0.19 (-1.93%)

07:08
09/19/18
09/19
07:08
09/19/18
07:08
Hot Stocks
Helius Medical announces partnership with Wexner Medical Center for PoNS clinic »

Helius Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMVKY

OMV AG

$0.00

(0.00%)

07:08
09/19/18
09/19
07:08
09/19/18
07:08
Upgrade
OMV AG rating change  »

OMV AG upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.